Revision of pharmaceutical affairs law unlikely to pass Assembly

Published: 2011-09-30 06:59:00

Updated: 2011-09-30 06:59:00

A bill to revise the Pharmaceutical Affairs Law, approved at the Cabinet meeting Tuesday, is facing opposition from lawmakers, with the prospect of the relevant bill passing the National Assembly appearing dim.

The Ministry of Health and Welfare is seeking to push the pharmaceutical law revisi...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK